Plasma VEGF-D and sFLT-1 are potential biomarkers of hemodynamics and congestion in heart failure and following heart transplantation
(2023) In JHLT Open 2.- Abstract
- Background
Inflammation and tyrosine-kinases are known mediators in the pathobiology of cardiovascular disease. Plasma biomarkers reflecting these systems may provide a noninvasive complement reflecting hemodynamics, aiding in clinical decision-making. We therefore aimed to investigate the plasma levels of vascular and inflammatory proteins, and their associations with invasive hemodynamics in advanced heart failure (HF) before, and at multiple follow-ups after heart transplantation (HT).
Methods
Using multiplex sandwich immunoassays, absolute plasma concentrations of 9 vascular and inflammatory proteins were assessed in 26 patients with advanced HF, before HT, and at 4 weeks, 6 months, and 1year after HT. Right heart... (More) - Background
Inflammation and tyrosine-kinases are known mediators in the pathobiology of cardiovascular disease. Plasma biomarkers reflecting these systems may provide a noninvasive complement reflecting hemodynamics, aiding in clinical decision-making. We therefore aimed to investigate the plasma levels of vascular and inflammatory proteins, and their associations with invasive hemodynamics in advanced heart failure (HF) before, and at multiple follow-ups after heart transplantation (HT).
Methods
Using multiplex sandwich immunoassays, absolute plasma concentrations of 9 vascular and inflammatory proteins were assessed in 26 patients with advanced HF, before HT, and at 4 weeks, 6 months, and 1year after HT. Right heart catheterization hemodynamics were assessed at the time of blood sampling. Repeated measures correlations were performed to evaluate the overall intra-individual development of plasma protein levels in relation to hemodynamics’ development over time.
Results
Out of 9 proteins included initially, in advanced HF, elevated plasma levels of vascular endothelial growth factor D (VEGF-D) and soluble fms-like tyrosine kinase-1 (sFlt-1) decreased most markedly at 4 weeks (p < 0.0001), and decreased further at 6 months (p < 0.05) and at the 1 year follow-ups after-HT (p < 0.05). Over time, plasma VEGF-D correlated strongest with hemodynamic parameters including pulmonary arterial wedge pressure (PAWP) (rmr = 0.75, 95% bootstrapped confidence interval (CI) 0.61-0.84, p < 0.0001), followed by mean right atrial pressure (MRAP) (rmr = 0.74, 95% CI 0.61-0.82, p < 0.0001), and mean pulmonary arterial pressure (mPAP) (rmr = 0.74, 95% CI 0.58-0.82, p < 0.0001). Plasma sFlt-1 correlated also with multiple hemodynamic parameters including PAWP (rmr = 0.66, 95% CI 0.58-0.79, p < 0.0001), MRAP (rmr = 0.64, 95% CI 0.58-0.81, p < 0.0001), and mPAP (rmr = 0.61, 95% CI 0.51-0.76, p < 0.0001).
Conclusions
In advanced HF, elevated plasma VEGF-D and sFlt-1 levels decrease early, already within 4 weeks after HT, and further throughout the first year postoperatively. Our findings support that high plasma VEGF-D and sFlt-1 concentrations before HT are related to congestion and overall hemodynamic improvement. Plasma VEGF-D and sFlt-1 may consequently be potential noninvasive biomarkers for monitoring hemodynamic deterioration and congestion in HF, and surveillance after HT. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/f416e6c2-d8f7-4d3c-aacd-82253452c930
- author
- Ahmed, Salaheldin
LU
; Lundgren, Jakob LU ; Ahmed, Abdulla LU
and Rådegran, Göran LU
- organization
- publishing date
- 2023-12-01
- type
- Contribution to journal
- publication status
- published
- subject
- in
- JHLT Open
- volume
- 2
- article number
- 100013
- publisher
- Elsevier
- ISSN
- 2950-1334
- DOI
- 10.1016/j.jhlto.2023.100013
- language
- English
- LU publication?
- yes
- id
- f416e6c2-d8f7-4d3c-aacd-82253452c930
- date added to LUP
- 2025-03-26 14:10:14
- date last changed
- 2025-04-04 14:12:55
@article{f416e6c2-d8f7-4d3c-aacd-82253452c930, abstract = {{Background<br/>Inflammation and tyrosine-kinases are known mediators in the pathobiology of cardiovascular disease. Plasma biomarkers reflecting these systems may provide a noninvasive complement reflecting hemodynamics, aiding in clinical decision-making. We therefore aimed to investigate the plasma levels of vascular and inflammatory proteins, and their associations with invasive hemodynamics in advanced heart failure (HF) before, and at multiple follow-ups after heart transplantation (HT).<br/><br/>Methods<br/>Using multiplex sandwich immunoassays, absolute plasma concentrations of 9 vascular and inflammatory proteins were assessed in 26 patients with advanced HF, before HT, and at 4 weeks, 6 months, and 1year after HT. Right heart catheterization hemodynamics were assessed at the time of blood sampling. Repeated measures correlations were performed to evaluate the overall intra-individual development of plasma protein levels in relation to hemodynamics’ development over time.<br/><br/>Results<br/>Out of 9 proteins included initially, in advanced HF, elevated plasma levels of vascular endothelial growth factor D (VEGF-D) and soluble fms-like tyrosine kinase-1 (sFlt-1) decreased most markedly at 4 weeks (p < 0.0001), and decreased further at 6 months (p < 0.05) and at the 1 year follow-ups after-HT (p < 0.05). Over time, plasma VEGF-D correlated strongest with hemodynamic parameters including pulmonary arterial wedge pressure (PAWP) (rmr = 0.75, 95% bootstrapped confidence interval (CI) 0.61-0.84, p < 0.0001), followed by mean right atrial pressure (MRAP) (rmr = 0.74, 95% CI 0.61-0.82, p < 0.0001), and mean pulmonary arterial pressure (mPAP) (rmr = 0.74, 95% CI 0.58-0.82, p < 0.0001). Plasma sFlt-1 correlated also with multiple hemodynamic parameters including PAWP (rmr = 0.66, 95% CI 0.58-0.79, p < 0.0001), MRAP (rmr = 0.64, 95% CI 0.58-0.81, p < 0.0001), and mPAP (rmr = 0.61, 95% CI 0.51-0.76, p < 0.0001).<br/><br/>Conclusions<br/>In advanced HF, elevated plasma VEGF-D and sFlt-1 levels decrease early, already within 4 weeks after HT, and further throughout the first year postoperatively. Our findings support that high plasma VEGF-D and sFlt-1 concentrations before HT are related to congestion and overall hemodynamic improvement. Plasma VEGF-D and sFlt-1 may consequently be potential noninvasive biomarkers for monitoring hemodynamic deterioration and congestion in HF, and surveillance after HT.}}, author = {{Ahmed, Salaheldin and Lundgren, Jakob and Ahmed, Abdulla and Rådegran, Göran}}, issn = {{2950-1334}}, language = {{eng}}, month = {{12}}, publisher = {{Elsevier}}, series = {{JHLT Open}}, title = {{Plasma VEGF-D and sFLT-1 are potential biomarkers of hemodynamics and congestion in heart failure and following heart transplantation}}, url = {{http://dx.doi.org/10.1016/j.jhlto.2023.100013}}, doi = {{10.1016/j.jhlto.2023.100013}}, volume = {{2}}, year = {{2023}}, }